Blood clot properties, thrombin generation, and platelet activation in patients with dysglycemia and established atherosclerotic cardiovascular disease: The CASCARA study
Polish Heart Journal · 2024
DOI: 10.33963/v.phj.100024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polish Heart Journal, 2024. Verfasst von Aleksander Siniarski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland. Hauptthemen laut MEDLINE: Platelet Activation, Thrombin, Diabetes Mellitus, Type 2, Coronary Artery Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND: There is a strong link between coronary artery disease (CAD), type 2 diabetes (T2D) on one hand, and altered fibrin clot properties, including increased clot density, and unfavorable fibrin clot structure on the other. T2D-related changes in fibrin clots can increase cardiovascular (CV) disease risk, including future CV events. We aimed to assess fibrin clot properties, thrombin generation, and platelet activation in CAD patients with prediabetes (PD) or T2D, compared to CAD patients without glycemic disorders. METHODS: We allocated patients to three groups: 1) Those with angiographically established CAD but without glycemic abnormalities (CAD group); 2) individuals with PD and established CAD (CAD+PD group); and 3) patients with T2D and CAD (CAD+T2D group). We conducted comparisons across these groups for thrombin generation, fibrin clot permeability, fibrin clot lysis, and platelet activation. RESULTS: The final analysis included 116 eligible patients: 1) CAD group (n = 31); 2) CAD+PD (n = 42); and 3) CAD+T2D (n = 43). The CAD+T2D patients enrolled had well-controlled T2D (median HbA1c level of 5.90%; IQR: 5.7%-6.3%). We found no significant differences in thrombin generation, fibrin clot properties, or platelet activation markers across the three analyzed groups (all P-values >0.20). However, elevated interleukin-6 (IL-6) levels were noted in both the highest and lowest glucose concentration quartiles. Additionally, a substantial increase in endogenous thrombin potential (ETP) was observed in patients in the highest glycated hemoglobin quintile. CONCLUSIONS: Individuals with established CAD and concomitant PD or well-controlled T2D exhibited comparable fibrin clot phenotypes, thrombin generation potential, and platelet activation when compared to CAD patients without dysglycemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
- St. John Paul II Hospital, Kraków, Poland.
- Department of Bioinformatics and Telemedicine, Jagiellonian University Medical College, Faculty of Medicine, Kraków, Poland.
- Center for Digital Medicine and Robotics, Jagiellonian University Medical College, Kraków, Poland.
- Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland. grzegorz.gajos@uj.edu.pl.
- St. John Paul II Hospital, Kraków, Poland. grzegorz.gajos@uj.edu.pl.
Zitieren
APA
Siniarski, A., Gołębiowska-Wiatrak, R., Malinowski, K. P., & Gajos, G. (2024). Blood clot properties, thrombin generation, and platelet activation in patients with dysglycemia and established atherosclerotic cardiovascular disease: The CASCARA study. Polish Heart Journal. https://doi.org/10.33963/v.phj.100024
Vancouver
Siniarski A, Gołębiowska-Wiatrak R, Malinowski KP, Gajos G. Blood clot properties, thrombin generation, and platelet activation in patients with dysglycemia and established atherosclerotic cardiovascular disease: The CASCARA study. Polish Heart Journal. 2024. doi:10.33963/v.phj.100024
BibTeX
@article{Siniarski2024,
author = {Siniarski, Aleksander and Gołębiowska-Wiatrak, Renata and Malinowski, Krzysztof P and Gajos, Grzegorz},
title = {Blood clot properties, thrombin generation, and platelet activation in patients with dysglycemia and established atherosclerotic cardiovascular disease: The CASCARA study},
journal = {Polish Heart Journal},
year = {2024},
doi = {10.33963/v.phj.100024}
}
EUVIMED